Table 1.

Demographic and clinical features of the 14 DADA2 patients before HSCT

Patient IDSex/ethnicityAge at disease onset (y)Age at genetic diagnosis (y)DADA2 clinical manifestationsCD4, CD8, CD19, CD56 (n × 106/L)IgG (mg/dL)IgA (mg/dL)IgM (mg/dL)Previous treatmentReference
P001 M, white PRCA, HSM, alopecia, strabismus, recurrent fevers, aphthous ulcers 814, 459, 104, 60 605 40 <6 Prednisone, MMF, sirolimus, CsA 6, 21 
P002 F, Hispanic 21 Recurrent infections, ID 361, 262, 0, 32 NA NA NA Prednisone 20 
P003 F, white 11 Splenomegaly, ICH, livedo, arthritis 528, 211, 26, 30 NA NA NA Infliximab  
P004 F, white Pancytopenia, stroke, ICH, vasculitis, arthritis, HSM, HTN, CMP, ID 273, 222, 23, 29 354 34 9 Prednisone, etanercept, anakinra, azathioprine 19 
P005 M, white PRCA, LNP, HSM, recurrent infections 1763, 1037, 415, 104 426 <8 <6 Prednisone  
P006 F, white 14 15 PRCA, neutropenia 441, 276, 43, 35 499 11 15 Prednisone  
P007 M, white 0.5 13 PRCA, neutropenia, SAA, HSM, livedo, IDDM, GHD NA 360 60 30 None 17 
P008* M, white 0.5 PRCA, pancytopenia, splenomegaly, recurrent infections, LNP 653, 93, 11, 0.5 997 2.4 7 Prednisone, sirolimus, tacrolimus 16, 18 
P009* M, white 0.4 Anemia, neutropenia, HSM, LNP, IBD, SAH, TIA, recurrent infections 599, 278, 228, 147 436 17 54 Prednisone, azathioprine, sirolimus, etanercept  
P010 M, white 22 Anemia, lymphopenia, HSM, Livedo, ICH, HTN, optic nerve atrophy, PAN 50, 50, 1, 10 465 47 17 Prednisone, azathioprine, infliximab  
P011 F, white 2.5 PRCA, vasculitis, pancytopenia, epilepsy, HSM, aphthous ulcers 386, 257, 237, 41 1000 2.4 74 Prednisone  
P012 F, white 16 25 ITP, HSM, lymphoproliferation, recurrent infections, lung granuloma 1670, 1721, 106, 101 NA NA NA Prednisone, ATG  
P013 M, white 0.3 PRCA, neutropenia, splenomegaly, IBD, recurrent fevers, aphthous ulcers 607, 781, 685, 90 290 119 9 Prednisone, anakinra  
P014 M, Hispanic 18 PRCA, hepatopathy, aphthous ulcers NA NA NA NA Prednisone  
Patient IDSex/ethnicityAge at disease onset (y)Age at genetic diagnosis (y)DADA2 clinical manifestationsCD4, CD8, CD19, CD56 (n × 106/L)IgG (mg/dL)IgA (mg/dL)IgM (mg/dL)Previous treatmentReference
P001 M, white PRCA, HSM, alopecia, strabismus, recurrent fevers, aphthous ulcers 814, 459, 104, 60 605 40 <6 Prednisone, MMF, sirolimus, CsA 6, 21 
P002 F, Hispanic 21 Recurrent infections, ID 361, 262, 0, 32 NA NA NA Prednisone 20 
P003 F, white 11 Splenomegaly, ICH, livedo, arthritis 528, 211, 26, 30 NA NA NA Infliximab  
P004 F, white Pancytopenia, stroke, ICH, vasculitis, arthritis, HSM, HTN, CMP, ID 273, 222, 23, 29 354 34 9 Prednisone, etanercept, anakinra, azathioprine 19 
P005 M, white PRCA, LNP, HSM, recurrent infections 1763, 1037, 415, 104 426 <8 <6 Prednisone  
P006 F, white 14 15 PRCA, neutropenia 441, 276, 43, 35 499 11 15 Prednisone  
P007 M, white 0.5 13 PRCA, neutropenia, SAA, HSM, livedo, IDDM, GHD NA 360 60 30 None 17 
P008* M, white 0.5 PRCA, pancytopenia, splenomegaly, recurrent infections, LNP 653, 93, 11, 0.5 997 2.4 7 Prednisone, sirolimus, tacrolimus 16, 18 
P009* M, white 0.4 Anemia, neutropenia, HSM, LNP, IBD, SAH, TIA, recurrent infections 599, 278, 228, 147 436 17 54 Prednisone, azathioprine, sirolimus, etanercept  
P010 M, white 22 Anemia, lymphopenia, HSM, Livedo, ICH, HTN, optic nerve atrophy, PAN 50, 50, 1, 10 465 47 17 Prednisone, azathioprine, infliximab  
P011 F, white 2.5 PRCA, vasculitis, pancytopenia, epilepsy, HSM, aphthous ulcers 386, 257, 237, 41 1000 2.4 74 Prednisone  
P012 F, white 16 25 ITP, HSM, lymphoproliferation, recurrent infections, lung granuloma 1670, 1721, 106, 101 NA NA NA Prednisone, ATG  
P013 M, white 0.3 PRCA, neutropenia, splenomegaly, IBD, recurrent fevers, aphthous ulcers 607, 781, 685, 90 290 119 9 Prednisone, anakinra  
P014 M, Hispanic 18 PRCA, hepatopathy, aphthous ulcers NA NA NA NA Prednisone  

Bold font indicates low values for age.

ATG, antithymocyte globulin; CMP, cardiomyopathy; CsA, cyclosporine A; F, female; GHD, growth hormone deficiency; HSM, hepatosplenomegaly; HTN, hypertension; ICH, intracranial hemorrhage; IBD, inflammatory bowel disease; ID, immunodeficiency; IDDM, insulin dependent diabetes mellitus; LNP, lymphadenopathy; M, male; MMF, mycophenolate mofetil; NA, not available; PAN, polyarteritis nodosa; SAH: subarachnoid hemorrhage; TIA: transient ischemic attack.

*

Siblings.

Close Modal

or Create an Account

Close Modal
Close Modal